The AHA yesterday urged the Centers for Medicare & Medicaid Services to take additional steps before using Worksheet S-10 data to determine a hospital’s uncompensated care, given the impa
News
Latest
Beginning today through May 5, hospitals participating in the inpatient, outpatient and prospective payment system-exempt cancer hospital quality reporting programs can
Thirty-two organizations, including hosp
The AHA’s Hospitals Against Violence 
The House Judiciary Committee today voted 16-10 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (
The House of Representatives today approved legislation (S. 544) extending the Veterans Choice Program.
Trustee Insights, the AHA’s new quarte
The AHA today urged Congress to provide law enforcement and other appropriate agencies with the resources to investigate cyber attacks and proactively prevent them.
Birth defects were reported in 10% of the 250 completed pregnancies with laboratory-confirmed Zika virus infection reported to the U.S.
The AHA, along with Baxter International Foundation and the Health Research & Educational Trust, is accepting
The Centers for Medicare & Medicaid Services this afternoon announced
The Centers for Medicare & Medicaid Services is working to finalize updated guidance related to co-location, which should clarify policies governing how hospitals can share space with other pro
Overall cancer death rates continue to decrease in men, women and children for all major racial and ethnic groups, according to the latest
The Kansas House of Representatives today failed by three votes to override the governor’s veto of legislation to expand Medicaid eligibility to low-income uninsured adults.
April is National Minority Health Month, dedicated to raising awareness about the health disparities tha
The Centers for Medicare & Medicaid Services March 30 issued a
The Centers for Medicare & Medicaid Services today proposed delaying the effecti
An experimental DNA vaccine to protect against disease caused by Zika infection has advanced to a larger study in humans, which will further evaluate the vaccine’s safety and immune response